392 related articles for article (PubMed ID: 23417891)
1. Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin.
Handrup MM; Møller JK; Schrøder H
Pediatr Blood Cancer; 2013 Aug; 60(8):1292-8. PubMed ID: 23417891
[TBL] [Abstract][Full Text] [Related]
2. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
3. Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.
Handrup MM; Fuursted K; Funch P; Møller JK; Schrøder H
APMIS; 2012 Oct; 120(10):794-801. PubMed ID: 22958287
[TBL] [Abstract][Full Text] [Related]
4. Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial.
Tribler S; Brandt CF; Petersen AH; Petersen JH; Fuglsang KA; Staun M; Broebech P; Moser CE; Jeppesen PB
Am J Clin Nutr; 2017 Sep; 106(3):839-848. PubMed ID: 28793993
[No Abstract] [Full Text] [Related]
5. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
Dümichen MJ; Seeger K; Lode HN; Kühl JS; Ebell W; Degenhardt P; Singer M; Geffers C; Querfeld U
J Hosp Infect; 2012 Apr; 80(4):304-9. PubMed ID: 22342714
[TBL] [Abstract][Full Text] [Related]
6. A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients.
Gudiol C; Arnan M; Aguilar-Guisado M; Royo-Cebrecos C; Sánchez-Ortega I; Montero I; Martín-Gandul C; Laporte-Amargós J; Albasanz-Puig A; Nicolae S; Perayre M; Berbel D; Tebe C; Riera J; Sureda A; Cisneros JM; Carratalà J
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712211
[TBL] [Abstract][Full Text] [Related]
7. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
[TBL] [Abstract][Full Text] [Related]
8. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
[TBL] [Abstract][Full Text] [Related]
9. Taurolidine-citrate-heparin catheter lock solution reduces staphylococcal bacteraemia rates in haemodialysis patients.
Murray EC; Deighan C; Geddes C; Thomson PC
QJM; 2014 Dec; 107(12):995-1000. PubMed ID: 24939191
[TBL] [Abstract][Full Text] [Related]
10. Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock.
Chu HP; Brind J; Tomar R; Hill S
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):403-7. PubMed ID: 22595973
[TBL] [Abstract][Full Text] [Related]
11. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial.
Bisseling TM; Willems MC; Versleijen MW; Hendriks JC; Vissers RK; Wanten GJ
Clin Nutr; 2010 Aug; 29(4):464-8. PubMed ID: 20061070
[TBL] [Abstract][Full Text] [Related]
12. Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation.
Jiménez Hernández M; Soriano A; Filella X; Calvo M; Coll E; Rebled JM; Poch E; Graterol F; Compte MT; Maduell F; Fontsere N
J Vasc Access; 2021 May; 22(3):370-379. PubMed ID: 32691665
[TBL] [Abstract][Full Text] [Related]
13. Taurolidine lock solution for catheter-related bloodstream infections in pediatric patients: A meta-analysis.
Sun Y; Wan G; Liang L
PLoS One; 2020; 15(4):e0231110. PubMed ID: 32255798
[TBL] [Abstract][Full Text] [Related]
14. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.
Cesaro S; Tridello G; Cavaliere M; Magagna L; Gavin P; Cusinato R; Zadra N; Franco Zanon G; Zanesco L; Carli M
J Clin Oncol; 2009 Apr; 27(12):2059-65. PubMed ID: 19273702
[TBL] [Abstract][Full Text] [Related]
15. Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: A randomised controlled multi-centre trial.
Schoot RA; van Ommen CH; Stijnen T; Tissing WJ; Michiels E; Abbink FC; Raphael MF; Heij HA; Lieverst JA; Spanjaard L; Zwaan CM; Caron HN; van de Wetering MD
Eur J Cancer; 2015 Sep; 51(14):2031-8. PubMed ID: 26188849
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer.
van den Bosch CH; van Woensel J; van de Wetering MD
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD003295. PubMed ID: 34617602
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study.
Al-Ali F; Hamdy AF; Hamad A; Elsayed M; Zafar Iqbal Z; Elsayed A; Ibrahim R; Tolba H; Buanan H; Fawzy A
Nephrol Dial Transplant; 2018 Apr; 33(4):619-626. PubMed ID: 29106676
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients.
van de Wetering MD; van Woensel JB; Lawrie TA
Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD003295. PubMed ID: 24277633
[TBL] [Abstract][Full Text] [Related]
19. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial.
Kanaa M; Wright MJ; Akbani H; Laboi P; Bhandari S; Sandoe JA
Am J Kidney Dis; 2015 Dec; 66(6):1015-23. PubMed ID: 26141306
[TBL] [Abstract][Full Text] [Related]
20. Taurolidine/Heparin Lock Solution and Catheter-Related Bloodstream Infection in Hemodialysis: A Randomized, Double-Blind, Active-Control, Phase 3 Study.
Agarwal AK; Roy-Chaudhury P; Mounts P; Hurlburt E; Pfaffle A; Poggio EC
Clin J Am Soc Nephrol; 2023 Nov; 18(11):1446-1455. PubMed ID: 37678222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]